News and Media

Latest News Release
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

Top feature box IMAGE ONLY - COMPANY NEWS

Press Releases

Cardinal Health Acquires mscripts®
04/24/2019
Company expands technological capabilities to deliver quality solutions to patients

DUBLIN, Ohio, April 24, 2019 — Cardinal Health today announced the acquisition of mscripts®, a company that delivers patient adherence and engagement solutions through an innovative, easy-to-use mobile and web-based health management platform. 

mscripts®, founded in 2008, was created to provide a digital communication platform to help patients stay on track with their healthcare by delivering targeted messages through mobile and web applications tied directly to the pharmacy dispensing system. The personalized support delivered through mobile pharmacy reminders encourages patient adherence to prescription medications and delivers cost savings directly to patients. Engaging patients through this experience supports overall health management.

"Cardinal Health is excited to broaden the capabilities we deliver to our customers that serve to strengthen the relationship between healthcare providers payers, pharmacies and patients,” said Debbie Weitzman, President, U.S. Pharmaceutical Distribution. “We understand the importance of reducing healthcare costs across the continuum of care. The capabilities we gain from the acquisition of mscripts® support patient adherence to prescriptions and improve overall health results.”       

“We are excited to join Cardinal Health, and we share in the company’s vision to provide inventive and meaningful solutions to improve patient outcomes and decrease the cost of care,” said Mark Cullen, CEO of mscripts®.

About Cardinal Health 
Cardinal Health, Inc. is a global, integrated healthcare services and products company, providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. The company provides clinically proven medical products, pharmaceuticals and cost-effective solutions that enhance supply chain efficiency from hospital to home. To help combat prescription drug abuse, the company and its education partners created Generation Rx, a national drug education and awareness program. Backed by nearly 100 years of experience, with approximately 50,000 employees in nearly 46 countries, Cardinal Health ranks #14 on the Fortune 500. For more information, visit cardinalhealth.com, follow @CardinalHealth on Twitter, @cardinalhealthwings on Facebook and connect on LinkedIn at linkedin.com/ company/cardinal-health.

For further information: For further information: Media: Brandi Martin, 614.757.3383, brandi.martin@cardinalhealth.com; or Investors: Lisa Capodici, 614.757.5035, lisa.capodici@cardinalhealth.com
More Company News
08/01/2022

Greene previously served as SVP of EIT for the company's Pharmaceutical Segment DUBLIN, Ohio, Aug. 1, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that Michelle Greene has been...

07/22/2022

TO: ALL PERSONS AND ENTITIES THAT HELD CARDINAL HEALTH, INC. COMMON STOCK AS OF THE CLOSE OF TRADING ON MAY 25, 2022 AND THAT CONTINUE TO HOLD CARDINAL HEALTH COMMON STOCK AS OF THE CLOSE OF...

07/06/2022

Strengthening Cornerstone Rheumatology™ GPO as a leading rheumatology-focused GPO by providing innovative solutions and robust specialty drug access to over 1,300 rheumatology providers nationwide.

06/29/2022

Cardinal Health (NYSE: CAH) today announced the launch of an inventory reserve program that helps labs and health systems more accurately pre-order respiratory diagnostics before the onset of...

View all company news »

* Required Fields